Hermed Capital: A China-based private equity firm specializing in healthcare industry investments.
Location
Shanghai, CN
Founded
2014
Hermed Capital is a private equity firm focused on healthcare industry investments in China. The firm typically invests in various stages, including Series A, B, C, and D rounds, as well as post-IPO equity and debt financing.
Notable portfolio companies include Aadi Bioscience, Epic Sciences, and Prognos Health. Hermed Capital's investments span a range of healthcare sectors, including biopharmaceuticals, medical devices, and healthcare technology. The firm's expertise in the Chinese healthcare market positions it to provide valuable insights and support to its portfolio companies.
Hermed Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count6
Top Investment Stages
Series A1 (25.0%)
Series B1 (25.0%)
Series C1 (25.0%)
Series D1 (25.0%)
Stage Mix
Series A 25%Series B 25%Series C 25%Series D 25%
Concentration shown as share of disclosed investments by stage.